Dechra Pharmaceuticals PLC Director/PDMR Shareholdings (7894M)

TIDMDPH

RNS Number : 7894M

Dechra Pharmaceuticals PLC

18 September 2019

18 September 2019

Dechra Pharmaceuticals PLC

Notification of Transactions by Persons Discharging Managerial Responsibilities

On 17 September 2019, Dechra Pharmaceuticals PLC was notified by Directors of the Company and Persons Discharging Managerial Responsibilities that they had completed the sale of part of their beneficial interest in Dechra.

Ian Page, Executive Director and Tony Rice, Non-Executive Chairman, have sold 200,000 ordinary shares and 20,000 ordinary shares respectively in the Company to satisfy long term personal financial planning considerations and widen their investment portfolios. The shares have been placed in the market with investors. Following these transactions, Ian Page will continue to retain a beneficial holding of 586,650 which represents 0.571% and Tony Rice, 20,000 representing 0.019% of the current issued share capital in the Company.

The Notification of Dealing Forms set out below are provided in accordance with Article 19.3 of MAR.

Notification of Dealing Form:

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                   Ian Page 
     -------------------------------------  ---------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/status                        Director 
     -------------------------------------  ---------------------------------- 
 b)   Initial notification/amendment         Initial Notification 
     -------------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
     ------------------------------------------------------------------------- 
 a)   Name                                   Dechra Pharmaceuticals PLC 
     -------------------------------------  ---------------------------------- 
 b)   LEI code                               213800J4UVB5OWG8VX82 
     -------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ------------------------------------------------------------------------- 
 a)   Description of the financial           Ordinary Shares of 1 pence each 
       instrument                             ISIN: GB0009633180 
       Identification code 
     -------------------------------------  ---------------------------------- 
 b)   Nature of the transaction              Sale of Shares 
     -------------------------------------  ---------------------------------- 
 c)   Price(s) and volumes(s)                Price(s)            Volume(s) 
                                              GBP29.1695          200,000 
     -------------------------------------  ------------------  -------------- 
 d)        Aggregated information 
             *    Aggregate volume             200,000 
                                               GBP29.1695 
                                               GBP5,833,900 
             *    Price 
 
 
             *    Total 
     -------------------------------------  ---------------------------------- 
 e)   Date of the transaction                17 September 2019 
     -------------------------------------  ---------------------------------- 
 f)   Place of the transaction               London Stock Exchange 
     -------------------------------------  ---------------------------------- 
 

Notification of Dealing Form:

 
 1.   Details of the Person Discharging Managerial Responsibility 
       ("PDMR")/person closely associated with them ("PCA") 
 a)   Name                                  Tony Rice 
     ------------------------------------  ---------------------------------- 
 2.   Reason for the notification 
     ------------------------------------------------------------------------ 
 a)   Position/status                       Director 
     ------------------------------------  ---------------------------------- 
 b)   Initial notification/amendment        Initial Notification 
     ------------------------------------  ---------------------------------- 
 3.   Details of the Issuer 
     ------------------------------------------------------------------------ 
 a)   Name                                  Dechra Pharmaceuticals PLC 
     ------------------------------------  ---------------------------------- 
 b)   LEI code                              213800J4UVB5OWG8VX82 
     ------------------------------------  ---------------------------------- 
 4.   Details of the transaction(s): section to be repeated for 
       (i) each type of instrument; (ii) each type of transaction; 
       (iii) each date; and (iv) each place where transactions have 
       been conducted 
     ------------------------------------------------------------------------ 
 a)   Description of the financial          Ordinary Shares of 1 pence each 
       instrument                            ISIN: GB0009633180 
       Identification code 
     ------------------------------------  ---------------------------------- 
 b)   Nature of the transaction             Sale of Shares 
     ------------------------------------  ---------------------------------- 
 c)   Price(s) and volumes(s)               Price(s)             Volume(s) 
                                             GBP29.09968          20,000 
     ------------------------------------  -------------------  ------------- 
 d)        Aggregated information 
             *    Aggregate volume            20,000 
                                              GBP29.09968 
                                              GBP581,993.60 
             *    Price 
 
 
             *    Total 
     ------------------------------------  ---------------------------------- 
 e)   Date of the transaction               17 September 2019 
     ------------------------------------  ---------------------------------- 
 f)   Place of the transaction              London Stock Exchange 
     ------------------------------------  ---------------------------------- 
 
 
 Enquiries: 
 Dechra Pharmaceuticals PLC 
 Ishbel Macpherson, Senior                 Office: [phone] 
  Independent Director 
 Ian Page, Chief Executive                 Office: [phone] 
  Officer 
 Paul Sandland, Acting Chief               Office: [phone] 
  Financial Officer 
  e-mail: [e-mail] 
 
 TooleyStreet Communications 
  Ltd 
 Fiona Tooley, Director                    Office: [phone] 
  e-mail: [e-mail]            Mobile: [phone] 
----------------------------------------  ------------------------------ 
 

About Dechra

Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com

Trademarks

Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

DSHSFMSAAFUSEEU

(END) Dow Jones Newswires

September 18, 2019 04:32 ET (08:32 GMT)